TradingKey

關於 Puma Biotechnology Inc 公司

Puma Biotechnology, Inc. 是一家生物製藥公司。該公司專注於開發和商業化產品以增強癌症治療。該公司的主要產品是 NERLYNX，一種口服的 neratinib，用於治療 HER2 陽性乳腺癌。Neratinib 是一種強效的不可逆酪氨酸激酶抑制劑 (TKI)，可阻斷通過表皮生長因子受體 HER1、HER2 和 HER4 的信號轉導。該公司還參與了 alisertib 的開發和商業化。 Alisertib 是一種選擇性小分子極光激酶 A 抑制劑，旨在破壞有絲分裂，導致依賴極光激酶 A 的快速增殖腫瘤細胞凋亡。其來那替尼在治療其他幾種癌症方面也有臨牀應用，包括 HER2 或表皮生長因子受體 (EGFR) 過度表達或突變的其他腫瘤類型，例如乳腺癌、宮頸癌、肺癌或其他實體瘤。

公司簡介

公司代碼PBYI

公司名稱Puma Biotechnology Inc

上市日期Mar 21, 2012

CEOMr. Alan H. Auerbach

員工數量172

證券類型Ordinary Share

年結日Mar 21

公司地址10880 Wilshire Blvd.

城市LOS ANGELES

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編90024

電話14242486500

網址https://www.pumabiotechnology.com/

公司代碼PBYI

上市日期Mar 21, 2012

CEOMr. Alan H. Auerbach

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Alan H. Auerbach

Chairman of the Board, President, Chief Executive Officer, Secretary

6.90M

-0.68%

Mr. Brian M. Stuglik

Independent Director

94.96K

+24.85%

Ms. Allison Dorval, CPA

Independent Director

75.39K

+25.65%

Mr. Jay M. Moyes, CPA

Lead Independent Director

53.32K

+10.35%

Dr. Alessandra Cesano, M.D., Ph.D.

Independent Director

41.85K

-39.22%

Dr. Adrian M. Senderowicz, M.D.

Independent Director

27.00K

--

Dr. Troy E. Wilson, J.D., Ph.D.

Independent Director

--

Mr. Douglas Hunt

Chief Regulatory Affairs, Medical Affairs, Pharmacovigilance, and Law Officer

--

Mr. Michael P. (Mike) Miller

Independent Director

--

Mr. Mariann Ohanesian

Investor Relations

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Alan H. Auerbach

Chairman of the Board, President, Chief Executive Officer, Secretary

6.90M

-0.68%

Mr. Brian M. Stuglik

Independent Director

94.96K

+24.85%

Ms. Allison Dorval, CPA

Independent Director

75.39K

+25.65%

Mr. Jay M. Moyes, CPA

Lead Independent Director

53.32K

+10.35%

Dr. Alessandra Cesano, M.D., Ph.D.

Independent Director

41.85K

-39.22%

Dr. Adrian M. Senderowicz, M.D.

Independent Director

27.00K

--

收入明細

暫無數據

暫無數據

業務

地區

暫無數據

股東統計

更新時間: 7月1日週二

持股股東

股東類型

持股股東

佔比

Auerbach (Alan H)

13.90%

Acorn Capital Advisors, LLC

7.94%

The Vanguard Group, Inc.

7.39%

BlackRock Institutional Trust Company, N.A.

6.05%

Acadian Asset Management LLC

4.05%

Other

60.67%

持股股東

佔比

Auerbach (Alan H)

13.90%

Acorn Capital Advisors, LLC

7.94%

The Vanguard Group, Inc.

7.39%

BlackRock Institutional Trust Company, N.A.

6.05%

Acadian Asset Management LLC

4.05%

Other

60.67%

股東類型

持股股東

佔比

Investment Advisor

32.15%

Investment Advisor/Hedge Fund

22.16%

Individual Investor

15.50%

Hedge Fund

9.95%

Research Firm

1.20%

Pension Fund

0.39%

Venture Capital

0.25%

Bank and Trust

0.09%

Insurance Company

0.03%

Other

18.26%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

252

40.67M

81.93%

-7.05M

2025Q1

256

39.74M

80.10%

-6.90M

2024Q4

254

38.30M

77.36%

-8.34M

2024Q3

246

40.62M

82.78%

-5.24M

2024Q2

238

41.70M

86.51%

-237.42K

2024Q1

243

40.11M

83.30%

-422.18K

2023Q4

241

36.65M

77.08%

-4.19M

2023Q3

280

35.58M

74.91%

-9.53M

2023Q2

294

33.81M

72.39%

-18.15M

2023Q1

308

36.08M

77.40%

-14.44M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

Auerbach (Alan H)

6.95M

13.99%

-21.51K

-0.31%

Apr 21, 2025

Acorn Capital Advisors, LLC

3.94M

7.94%

--

Mar 31, 2025

The Vanguard Group, Inc.

3.67M

7.39%

+25.84K

+0.71%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

3.00M

6.05%

-48.98K

-1.60%

Mar 31, 2025

Acadian Asset Management LLC

2.01M

4.05%

+36.02K

+1.83%

Mar 31, 2025

Renaissance Technologies LLC

1.83M

3.69%

+73.70K

+4.20%

Mar 31, 2025

Millennium Management LLC

1.39M

2.79%

-508.93K

-26.87%

Mar 31, 2025

Athyrium Capital Management, LP

1.26M

2.53%

--

Sep 30, 2024

American Century Investment Management, Inc.

1.15M

2.32%

+201.28K

+21.22%

Mar 31, 2025

Geode Capital Management, L.L.C.

955.46K

1.92%

+36.02K

+3.92%

Mar 31, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

Janus Henderson Small Cap Growth Alpha ETF

0.67%

Royce Quant Small-Cap Quality Value ETF

0.25%

Janus Henderson Small/Mid Cap Growth Alpha ETF

0.23%

Lattice Hartford Multifactor Small Cap ETF

0.11%

WisdomTree US SmallCap Fund

0.04%

iShares Micro-Cap ETF

0.03%

Franklin US Small Cap Multifactor Index ETF

0.02%

Fidelity Enhanced Small Cap ETF

0.02%

Avantis US Small Cap Equity ETF

0.02%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.02%

Janus Henderson Small Cap Growth Alpha ETF

佔比0.67%

Royce Quant Small-Cap Quality Value ETF

佔比0.25%

Janus Henderson Small/Mid Cap Growth Alpha ETF

佔比0.23%

Lattice Hartford Multifactor Small Cap ETF

佔比0.11%

WisdomTree US SmallCap Fund

佔比0.04%

iShares Micro-Cap ETF

佔比0.03%

Franklin US Small Cap Multifactor Index ETF

佔比0.02%

Fidelity Enhanced Small Cap ETF

佔比0.02%

Avantis US Small Cap Equity ETF

佔比0.02%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

佔比0.02%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Puma Biotechnology Inc

3.180USD

Puma Biotechnology Inc

3.180

概覽

公司

財務